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General characteristics of the species  
and position in medicine
Calendula officinalis L. is a species belonging 
to the family Asteraceae, formerly Compositae. The 
name of the species – Calendula – comes from the 
Latin word calends, meaning the first day of each 
month, which is associated with the flowering periods 
of the plant [Basch et al. 2006, Arora et al. 2013, John 
et al. 2017]. C. officinalis is an annual or biennial her-
baceous plant, reaching from 30 to 60 cm in height. 
Distinctive features of the plant’s appearance are het-
erophylly (in a single individual, the lower leaves are 
ovoid and upper are lanceolate) and the basket-type 
inflorescence composed of two types of flowers (so-
called ligular flowers on the external side of the in-
florescence, and tubular flowers on the internal side). 
Typically, the inflorescences are yellow-orange, but 
there are also marigold cultivars with light-yellow and 
dark-orange flowers. The flowering period of marigold 
in Europe is from June to September. Importantly, all 
parts of the plant are covered with glandular hairs of 
a multicellular structure where the essential oil is pro-
duced [Arora et al. 2013, European Pharmacopoeia 
9.0 2017, Farmakopea Polska XI 2017].
Natural marigolds localities are found in Europe in 
the Mediterranean region and the Middle East. Cur-
rently, it is a widespread and valued plant cultivated 
for medicinal and ornamental purposes also in other 
parts of Europe (the Balkans, Eastern Europe and Ger-
many) as well as in North America [Basch et al. 2006, 
John et al. 2017].
Marigold inflorescence is a long-known healing 
raw material in folk medicine. The first written records 
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about its application date back to the 12th century [Bin-
gen 1155]. Traditionally, it has been used externally 
to treat small wounds, burns and other skin problems. 
This application in dermatological diseases, also 
known today, has been the subject of previous reviews 
regarding C. officinalis [Arora et al. 2013, Leach 2008, 
Muley et. al. 2009, Paul et al. 2018, Preethi and Kuttan 
2009, Shafeie et al. 2015]. 
Mature, dried marigold flowers (syn. calendula in-
florescences, calendula baskets, calendula basket in-
florescence) – Calendulae flos – are currently used as 
pharmaceutical raw material in official phytotherapy. 
A monograph with such a title is listed in the Europe-
an Pharmacopoeia 9th [European Pharmacopoeia 9.0 
2017]. According to pharmacopoeial guidelines, the 
raw material should contain more than 0.4% of flavo-
noids, calculated per hyperoside [European Pharma-
copoeia 9.0 2017]. 
Calendula flower also has a positive opinion of 
the European Scientific Cooperative on Phytother-
apy [ESCOP] and the Committee on Herbal Medic-
inal Products (HMPC) specifically appointed by the 
European Medicines Agency [EMA]. Since 2004, this 
raw material has been also described in a monograph 
entitled Flos Calendulae in the International Phar-
macopoeia issued by the World Health Organization 
[WHO 2002]. The raw material has been also much 
longer included, since 1986, in phytotherapeutic 
monographs issued by German Commission E Mono-
graphs, Phytotherapy [1986].
In addition, C. officinalis is accepted by the Europe-
an Commission as a safe cosmetic ingredient [CosIng].
bioactive components
Many secondary metabolites are responsible for 
the biological activity of C. officinalis. The main 
group are flavonoid compounds, among others, 
aglycones: quercetin, isoquercetin, rutinoside, nar-
cissin, and glycosides: quercetin-3-rutinoside, isor-
hamnetin-3-neohesperidoside (calendoflavoside) and 
quercetin 3-neohesperidoside (calendoflavobioside) 
(Fig. 1, Tab. 1) [Arora et al. 2013, Khalid and Silva 
2012]. Calendoflaside is another specific compound 
belonging to the flavonoids that has been isolated 
for the first time from the marigold’s inflorescence in 
1989 (Fig. 1, Tab. 1) [Miguel et al. 2016].
Terpenoids are an important group of secondary 
metabolites, which occur in the C. officinalis inflo-
rescence and are responsible for its biological activity 
[Arora et al. 2013, Muley et al. 2009]. It is possible to 
distinguish in this group of compounds triterpendiol 
monoesters: esters of faradiol (faradiol-3-O-palmitate, 
faradiol-3-O-myristate, faradiol-3-O-laurate), esters of 
arnidiol (arnidiol-3-O-palmitate, arnidiol-3-O-myri-
state, arnidiol-3-O-laurate) and specific for C. of-
ficinalis – calenduladiol and its esters (calendula-
diol-3-O-palmitate, calenduladiol-3-O-myristate) 
[Arora et al. 2013, Khalid and Silva 2012]. Deriva-
tives of oleanolic acid – triterpenoid saponins: ca-
lendulosides A–H are an important, specific for 
C. officinalis compounds from the group of terpenoids 
(Fig. 2, Tab. 1) [Arora et al. 2013, Khalid and Silva 
2012, Muley et al. 2009]. Triterpenoid glycoside de-
rivatives of oleanolic acid, so-called calendulaglyco-
side A and B and their esters are also characteristic 
compounds that occur only in this species (Fig. 3, 
Tab. 1) [Grzelak and Janiszowska 2002, Ukiya et al. 
2006, Wiktorowska et al. 2010, Farahpour 2014].
The presence of coumarins (esculetin, scopoletin, 
umbelliferone), lipids (phospholipids, glycolipids), fi-
tosterols, aminoacids (alanine, leucine, lysine, methi-
onine) and saccharides has been also documented in 
C. officinalis infloresences (Tab. 1) [Arora et al. 2013, 
Khalid and Silva 2012].
In addition, compounds from the carotenoid group: 
α- and β-carotene, flavoxanthin, luteoxanthin, lyco-
pene and lutein and its derivatives were mainly isolat-
ed in the extracts of marigold flowers as well as in pol-
len and leaf extracts (Tab. 1) [Muley et al. 2009, Arora 
et al. 2013, Khalid and Silva 2012, Legha et al. 2012].
An important raw material obtained from C. of-
ficinalis flowers is an essential oil containing main-
ly terpenoid compounds from the monoterpenoid 
group, such as limonene, α-pinene, β-pinene, α-thu-
jene, sabinene, p-cymene and sesquiterpenoids, e.g. 
α-humulene, α-yanglene, germacrene D and nerolidol 
(Tab. 2). The percentage of essential oil content in 
inflorescences depends on the stage of plant develop-
ment. The largest production takes place during the 
flowering period of the plant [Muley et al. 2009, Kha-
lid and Silva 2012, Arora et al. 2013].
Characteristic metabolites of the family Asterace-
ae species are polysaccharides that affect the immune 
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Fig. 1. Chemical structures of flavonoids specific for C. officinalis  
CH3
CH3
CH3 H
CH3
O
OHCH3
CH3
OO
O
OH
OH
OH
O
OH
OH
OH
OH
CH3
 
CH3
CH3
CH3
CH3
HCH3
O
O
OH
O
OH
H
OHOH
CH3
CH3
OO
OHHO
OH
H
H
OH
OH
O
OH
H
H
OH
H
H
H OH
H
H
H
H
H
 
CH3
CH3
H
OH
O
CH3
CH3
H
CH3
H
CH3
CH3 O
O
O
OH
OOH
OH
O
OHOH
OH O
O
O
OH
OH
 
O
O
OH
OH
O
CH3
CH3
H
CH3
H
CH3
CH3
OH
OO
OH
OO
OH
OH
OH
OH
O
O
OH
OH
OH
OH
OH
OH
CH3
CH3
H
 
    
calenduloside A calenduloside B calenduloside C calenduloside D 
    
OO
OH
OH
OH
O
OH
CH3
CH3
H
CH3
H
CH3
H
O
OHCH3
CH3
CH3
 
CH3
CH3
O
O
O
OH
OH
OH
CH3
CH3
CH3 H
H
CH3CH3
OO
OH
OH
OH
O
OH
OH
H
 
OO
OH
O
OH
O
OH
OHOH
OH
CH3
CH3
O
OH
H
CH3
CH3
HCH3
H
CH3
CH3OH
O
 
O
O
OH
O
OH OH
OH
CH3
CH3
H
CH3
CH3
CH3
H
CH3
CH3
OO
OH
OH
O
OH
O
OH
OH
OH OH
O
H
 
    
calenduloside E calenduloside F calenduloside G calenduloside H 
Fig. 2. Chemical structures of C. officinalis-specific triterpenoid saponins (oleanolic acid derivaties): calendulosides A–H  
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 table 1. Chemical composition of C. officinalis 
Group of secondary metabolites Compounds References 
aglycones isoquercitrin, narcissin, quercetin, rutinoside 
Flavonoids 
glycosides 
calendoflaside, isorhamnetin-3-neohesperidoside 
(calendoflavoside), quercetin 3-neohesperidoside 
(calendoflavobioside),  
quercetin-3-O-rutinoside 
Ukiya et al. 2006,  
Kurkin and Sharova 
2007, Hernández-
Saavedra et al. 2016, 
Miguel et al. 2016 
triterpenoids erythrodiol, monoesters of lupeol, taraxasterol, ursadiol 
triterpendiol  
monoesters  
calenduladiol and its esters (calenduladiol-3-O-palmitate,  
calenduladiol-3-O-myristate),  
esters of arnidol (arnidiol-3-O-palmitate, arnidiol-3-O-myristate, 
arnidiol-3-O-laurate), 
esters of faradiol (faradiol-3-O-palmitate, faradiol-3-O-myristate, 
faradiol-3-O-laurate) 
triterpenoid  
saponins calendulosides A–H 
Terpenoids 
triterpenoid  
glycosides 
calendulaglycosides A and B and their esters: calendulaglycoside A 
6-O-n-methyl ester, calendulaglycoside A 6-O-n-butyl ester, 
calendulaglycoside B 6-O-n-butyl ester, glucuronides A, B, C, D, F 
Neukirch et al. 2004, 
Ruszkowski et al. 2005, 
Ukiya et al. 2006, 
Muley et al. 2009,  
Arora et al. 2013, 
Nizyński et al. 2015, 
Miguel et al. 2016, 
John et al. 2017 
Carotenoids  
auroxanthin, α-cryptoxanthin, α-carotene, β-carotene,  
β-cryptoxanthin, flavoxantin, lutein and its derivatives  
(9/9A-lutein, 13/13 Z-lutein), luteoxanthin, lycopene, 
neoxantin, 9Z-neoxantin, violaxanthin, 9Z-violaxanthin  
Muley et al. 2009, Legha 
et al. 2012, Arora et al. 
2013, John et al. 2017  
Coumarins  esculetin, scopoletin, umbelliferone Bakó et al. 2002 
Lipids  fatty acids: lauric acid, palmitic acid, stearic acid, linoleic acid,  glycolipids, phospholipids  John et al. 2017 
Fitosterols  stigmasterol, sitosterol Muley et al. 2009, Arora et al. 2013 
Amino acids  
alanine, arginine, aspartic acid, histidine, glutamic acid, 
leucine, lysine, methionine, phenylalanine, proline, serine,  
tyrosine, valine 
Muley et al. 2009, 
Arora et al. 2013,  
John et al. 2017 
Saccharides  arabinogalactan, neohesperidose and its derivatives,  ramnoarabinogalactan 
Muley et al. 2009 
Arora et al. 2013 
Benzofurans  calendin Colombo et al. 2015,  John et al. 2017 
 
 
table 2. Chemical composition of C. officinalis essential oil [Okoh et al. 2007, John et al. 2017] 
                                            Terpenoid compounds of C. officinalis essential oil 
Monoterpenoids 1,8-cineol, p-cymene, geraniol, limonene, ocimene, trans-β-ocimene, α-pinene, β-pinene,  sabinene, α-terpineol, terpinen-4-ol, α-thujene 
Sesquiterpenoids calarene, cadina-1,4-diene, δ-cadinen, α-cubebne, germacrene D,  α-humulene, α-kadinol, nerolidol, T-muurolol, epi-bicyclo-sesquiphellandrene, α-ylangene 
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Fig. 3. Chemical structures of C. officinalis-specific triterpenoid glycosides (glycosides of 
oleanolic acid): calendulaglycoside A and B 
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 table 3. Biological activity and mechanisms of C. officinalis effects confirmed by scientific research 
Biological activity Mechanism of action References 
Anti-inflammatory 
activity 
inhibition of ear edema in mice induced by irritants (flower extract containing 
faradiol monoesters), 
reduction of burn swellings in rats by using a cream with the addition of ethanol 
flower extract, 
inhibition of proinflammatory cytokines (IL-1β, Il-6, TNF-α and IFN-γ)  
and C-reactive protein (CRP) in mice with induced inflammation  
by lipopolysaccharide (LPS) injection (ethanol flower extracts), 
reduced inflammatory bone resorption (oral administration of the flower extract), 
reduction of symptoms of bacterial vaginosis in women of childbearing age  
(cream with flower extracts), 
reduction of myeloperoxidase, lactate dehydrogenase and lipid peroxidase  
activity in rat colitis (methanol flower extracts) 
Alexandre et al. 2018, 
Arora et al. 2013, 
Banakar et al. 2016, 
Farahpour 2014,  
Muley et al. 2009, 
Parente et al. 2012, 
Singh et al. 2011,  
Ukiya et al. 2006 
 
 
 
Wound healing  
acceleration  
activity 
increased granulation tissue formation by accelerating the metabolism  
of collagen, nucleoproteins and glycoproteins (flower extracts), 
increase in the rate of new blood vessel formation in skin wounds in rats  
(water flower extracts), 
reduction of collagenase activity (water and methanol extract from flowers  
and leaves), 
an increase in the rate of wound healing in patients with venous leg ulceration 
(hydroglycolic flower extracts), 
acceleration of healing, reduction of infection, itching, redness, pain in foot  
injuries in people with diabetes (cream with flower extracts), 
increase in the proliferation and migration of fibroblasts in human lung fibroblast 
cells, Swiss albino mouse fibroblast cells and human primary dermal fibroblast 
cells (ethanol flower extracts) 
Buzzi et al. 2016, 
Dinda et al. 2015,  
Gilca et al. 2018, 
Lovecka et al. 2018, 
Nicolaus et al. 2017, 
Paul et al. 2018 
 
Antibacterial  
activity 
Gram (+) bacteria: Actinomyces odontolyticus, Bacillus subtillis, Enterococcus 
faecalis, Micrococcus luteus, Peptostreptococcus micros, Staphulococcus aureus, 
Streptococcus mutans (water and methanol flower extracts), 
Gram (–) bacteria: Agrobacterium tumefaciens, Burkholderia glathei,  
Caphocytophaga gingivalis, Eikenella corrodens, Escherichia coli,  
Furobacterium nucleatum, Porphyromonas gingivalis, P. intermedia,  
Prevotella spp., Pseudomonas aeruginosa, P. syringae, Veilonella parvula,  
Vibrio cholerae (water and methanol flower extracts) 
Arora et al. 2013, 
Khalid and Silva 2012, 
Lovecka et al. 2018, 
Muley et al. 2009, 
Shankar et al. 2017, 
Singh et al. 2011 
Antifungal  
activity 
growth inhibition of Candida strains: C. albicans, C. dubliniensis,  
C. glabrata, C. krusei and C. parapsilosis (flower essential oil), 
growth inhibition of strains: Geotrichum candidum, Microsporum canis,  
M. gypseum, T. mentagrophytes, Trichophytom rubrum (methanol flower  
extracts) 
Faustino et al. 2018, 
Khalid and Silva 2012, 
Lovecka et al. 2018, 
Saffari et al. 2017 
Antiviral activity 
inhibition of HIV replication (organic solvent flower extracts), 
inhibition of herpes and influenza virus (flower tincture), 
moderate inhibitory effect on Epstein-Barr virus (EBV-EA) (C. officinalis  
triterpenenoid glycosides) 
Muley et al. 2009, 
Salehi et al. 2018,  
Ukiya et al. 2006 
Antitrichomona 
activity 
growth inhibition of Trichomonas vaginalis protozoan (components of the  
essential oil) 
Samochowiec et al. 
1979 
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 table 3 cont.  
Biological activity Mechanism of action References 
Antioxidant  
activity 
reduction of superoxide and hydroxyl radicals (butanol flower extracts), 
increase in the concentration of reduced glutathione (GSH), superoxide dismutase 
(SOD) and catalase (CAT) in periodontitis in rats (aqueous flower extracts), 
reduction of production of reactive oxygen species (ROS) in skin cells treated  
with H2O2 (ethanol flower extracts), inhibition of lipid peroxidation in rat liver  
microsomes (butanol flower extracts), reduction of malondialdehyde (MDA) 
concentration in periodontitis in rats (water flower extracts) 
Cordova et al. 2002, 
Farahpour 2014,  
Lima et al. 2017,  
Xuan et al. 2016 
Skin brightening  
effect 
inhibition of melanin production induced by alpha melanocyte-stimulating  
hormone in melanoma cells (flower ethyl acetate extracts) Xuan et al. 2019 
Spasmolytic  
activity inhibition of spontaneous intestine contractions (water-ethanol flower extracts) 
Arora et al. 2013, 
Muley et al. 2009 
Antidiabetic  
and hypolipemic  
activity 
reduction in blood and urine glucose levels in diabetes-induced rats  
(water-ethanol flower extract), 
restoration of normal blood and urine glucose concentration and blood lipids  
in diabetes-induced rats (high doses of water-ethanol flower extracts), 
reduction in blood glucose levels in hyperglycemic rabbits (extracts from  
C. officinalis, Salvia officinalis, Glycyrrhiza glabra, Echinacea purpurea), 
increase in liver glycogen levels in hyperglycemic rabbits (extracts from  
C. officinalis, Salvia officinalis, Glycyrrhiza glabra, Echinacea purpurea) 
Singh et al. 2011, 
Aghajanyan and 
Trchounian 2018, 
Singh et al. 2011 
Hepatoprotective and 
hepatoregenerative 
activity 
reduction of hepatocytolysis and inhibition of aspartate aminotransferase,  
alanine aminotransferase, lactate dehydrogenase, succinate dehydrogenase  
and cyclooxygenases activities (water-ethanol flower extracts), 
increase in the activity of reduced glutathione enzymes, superoxide dismutase, 
catalase and increase of adenosine triphosphate content in hepatocytes in the  
rat model of acute hepatitis (flower extracts) 
Muley et al. 2009, 
Singh et al. 2011, 
Toropova et al. 2017 
Pancreas  
regenerating  
activity 
increase in the production of nucleic acids, proteins, pancreatic amylase, and  
eduction of pancreatic oxidative stress in cells of the pancreatic parenchyma  
(ethanol flower extracts) 
Kaur et al. 2016 
Cardioprotective 
activity 
cardioprotective effect by regulating blood pressure and flow in the aorta and  
left ventricle (flower extracts), 
reduction in the extent of myocardial infarction and cardiomyocyte apoptosis  
in induced ischemic disease in rats (flower extracts) 
Singh et al. 2011 
Neuroprotective  
activity 
reduction of oxidative damage and striatal neuronal loss in rats with induced  
neurotoxicity (ethanol flower extracts) 
Shivasharan et al. 
2013 
Antitumor activity 
cytotoxic effect on cell lines: colon cancer, leukemia, melanoma and breast  
cancer (C. officinalis triterpenenoid glycosides), 
cytotoxic effect on Ehrlich tumor (flower extracts), 
inhibiting the growth of human liver cancer cells (flower extracts), 
inhibition of cell proliferation in human embryonic kidney (HEK 293T) and  
human liver cancer (HepG2) cell lines (ethanol and aqueous flower extracts) 
Lovecka et al. 2018, 
Muley et al. 2009, 
Ukiya et al. 2006 
 
Immunostimulatory 
activity increase in cell phagocytosis (C. officinalis polysaccharide fraction)  
Arora et al. 2013, 
Muley et al. 2009 
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system and sesquiterpenoid lactones with various 
biological activities. Marigold flowers were shown 
to contain polysaccharides (among others neohes-
peridoside and its derivatives, arabinogalactan, ram-
noarabinogalactan) with immunostimulatory proper-
ties, and sesquiterpenoid lactone – calendin (bitter 
constituent) [Muley et al. 2009, Arora et al. 2013, 
Colombo et al. 2015].
Interestingly, the sugar part of glycosidic combina-
tions present in flowers may be formed by lactose (milk 
sugar), which is a huge rarity in the plant kingdom. 
Neohesperidose (2-O-α-L-rhamnopyranosyl-D-gluco-
pyranose) is another characteristic disaccharide form-
ing glycons in glycoside combinations [Muley et al. 
2009, Arora et al. 2013, Colombo et al. 2015].
application in medicine
In modern phytotherapy, as in folk medicine, C. of-
ficinalis flower extracts are widely used mainly in the 
treatment of dermatological diseases (Tab. 3) [Basch 
et al. 2006, Muley et al. 2009, Arora et al. 2013]. Many 
scientific studies on this species focused on anti-in-
flammatory and accelerated wound healing proper-
ties [Ukiya et al. 2006, Parente et al. 2012, Farahpour 
2014, Buzzi et al. 2016, Nicolaus et al. 2017, Alexan-
dre et al. 2018, Paul et al. 2018]. Anti-inflammatory 
activity is conditioned by the presence of terpenoid 
compounds (Fig. 2 and 3, Tab. 1 and 3), the higher 
the content of these compounds, the stronger the effect 
of the extract [Ukiya et al. 2006]. It has been proven 
that the use of an ointment with C. officinalis inflo-
rescence extract reduces the incidence of dermatitis 
in people with breast cancer undergoing radiotherapy 
[Pommier et al. 2004]. In addition, ointments applied 
to skin wounds accelerate their healing by increasing 
epidermal epithelization [Paul et al. 2018]. New re-
search indicates that Calendula officinalis-loaded poly 
ε-caprolactone/gum arabic nanocomposite scaffolds, 
when applied on wounds, increase cell adhesion and 
proliferation as well as have an antibacterial effect. 
This composition is well suited for skin regeneration 
[Pedram Rad et al. 2019]. Extracts of C. officinalis in-
florescences can also be used for hard-to-heal wounds, 
such as venous ulcers, burns and other skin changes 
that are difficult to heal [Buzzi et al. 2016, Duran et al. 
2005]. According to the latest research, preparations 
containing marigold flower extracts can be used in 
non-invasive and delicate therapies, difficult-to-treat 
plantar papules, painful hyperkeratotic changes and 
inflammation of the hallux valgus [Duran et al. 2005, 
Singh et al. 2011] (Tab. 3). 
Extracts from C. officinalis inflorescences have 
scientifically proven antiviral, antibacterial, antifun-
gal and antiprotozoal activity. Based on scientific re-
search, it has been proven that C. officinalis extracts 
inhibit the activity of herpes and influenza virus, they 
also reduce HIV replication [Ukiya et al. 2006, Muley 
et al. 2009, Arora et al. 2013, Farahpour 2014, Salehi 
et al. 2018]. Extracts have an antibacterial effect on 
numerous strains of Gram (+) bacteria (incl. Bacillus 
subtillis, Peptostreptococcus micros, Staphulococcus 
aureus) and Gram (–) bacteria (incl. Escherichia coli, 
Furobacterium nucleatum, Porphyromonas gingi-
valis, Pseudomonas aeruginosa, Veilonella parvula, 
Vibrio cholerae) [Singh et al. 2011, Khalid and Sil-
va 2012, Shankar et al. 2017, Lovecka et al. 2018, 
Muley et al. 2009]. In addition, it has been proven 
that C. officinalis essential oil has a stronger inhibi-
tory effect on pathogenic fungal strains than nystatin 
[Khalid and Silva 2012] and inhibits the growth of the 
protozoan Trichomonas vaginalis [Samochowiec et 
al. 1979] (Tab. 3). 
Scientific studies have demonstrated that extracts 
of C. officinalis inflorescences have antioxidant, spas-
molytic, antidiabetic and hypolipemic effects [Cordo-
va et al. 2002, Muley et al. 2009, Singh et al. 2011, 
Xuan et al. 2016, Lima et al. 2017] (Tab. 3). In ad-
dition, the latest report showed their pancreas-regen-
erating, hepatoregenerative, cardioprotective and neu-
roregenerative activity [Muley et al. 2009, Singh et al. 
2011, Toropova et al. 2017]. Furthermore, triterpenoid 
glycosides found in C. officinalis inhibited the growth 
of tumor cell lines: colon cancer, breast cancer, leu-
kemia as well as melanoma in in vitro tests [Muley et 
al. 2009, Farahpour 2014, Ukiya et al. 2006]. In addi-
tion, the C. officinalis saccharide group was shown to 
act immunostimulatory [Muley et al. 2009, Arora 
et al. 2013] (Tab. 3). 
A detailed description of the mechanisms of ex-
tracts’ biological activity and/or individual compo-
nents of C. officinalis is presented in Tab. 3. 
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cosmetic applications
Calendula officinalis is a popular species in the 
cosmetics industry, especially due to the scientifically 
proven anti-inflammatory, antioxidant and skin dam-
age granulation accelerating properties [Anuradha et 
al. 2015]. Calendula is present mainly in the compo-
sition of cosmetics that have soothing, softening and 
regenerating effects. 
Recently, an increasing popularity of preparations 
based on extracts from C. officinalis has been observed. 
Therefore, research focused on the cosmetic application 
of C. officinalis flower extracts is of particular interest. 
In vitro studies on skin cells with induced oxidative stress 
have proven that ethanol extracts from C. officinalis 
flowers have a strong antioxidant effect, and protect cells 
from damaging effects of UV radiation [Xuan et al. 2016]. 
Other studies have shown that cream with C. officinalis 
flower extract stimulates skin cell regeneration, improves 
elasticity, and also induces increased skin hydration, as 
a result of lower TEWL (transepidermal water loss) 
[Buzzi et al. 2016]. It has also been proven that cream 
with C. officinalis inflorescences reduces sebum secre-
tion and has a brightening effect through the reduction of 
melanin content in the skin [Jadoon et al. 2015, Tundis 
et al. 2015]. Scientific studies have also demonstrated 
that the anti-aging effect of C. officinalis inflorescence 
extracts is related to the control of metalloproteinase 
(MMP-2 and MMP-9) secretion [Tundis et al. 2015]. 
Calendula officinalis oil is also applied in cosme-
tology. It has been proven that it has a stronger inhib-
itory effect on pathogenic fungal strains than nystat-
in [Khalid and Silva 2012] (Tab. 3). When used in 
emulsions, it accelerates wound healing and protects 
against UV radiation [Okuma et al. 2015, Lohani et al. 
2018,]. In addition, the oil has a stronger antioxidant 
activity than geranium oil [Lohani et al. 2018]. 
According to Cosmetic Ingredient Database 
[CosIng] – an on-line database of cosmetic ingredients 
introduced by the European Commission – C. officina-
lis, is a species that can be used in ten different forms 
(Tab. 4). Interestingly, recently, the Bulgarian compa-
ny Innova BM patented and introduced to the market 
two innovative cosmetic preparations based on C. of-
ficinalis cell cultures – with moisturizing, anti-aging 
and regenerating properties [Georgiev et al. 2018].
food application
In the past, marigold leaves were used in cuisine 
as a vegetable. Also today, fresh marigold flowers are 
added to salads. Dried flowers, as a substitute for saf-
fron, are a spice for soups and cakes; moreover, they 
are used for coloring of, among others, rice, fat (mar-
garine) and yellow cheeses. The safety of marigold 
flower use in food is confirmed by the European Food 
Safety Authority [EFSA] documentation.
safety of use
Caution should be exercised with allergy suffer-
ers when using or consuming preparations containing 
 table 4. C. officinalis in the cosmetic products acc. to CosIng database  
Name acc. to CosIng Cosmetic activity 
Calendula officinalis extract skin conditioning 
Calendula officinalis callus extract skin conditioning, skin protective, emollient 
Calendula officinalis flower skin conditioning 
Calendula officinalis flower extract skin conditioning, masking, perfuming 
Calendula officinalis flower oil skin conditioning, masking, perfuming 
Calendula officinalis flower water masking, flavouring, perfuming 
Calendula officinalis flower/leaf/stem juice skin conditioning 
Calendula officinalis meristem cell extract antioxidant 
Calendula officinalis seed oil skin conditioning 
Hydrolyzed Calendula officinalis flower extract skin protective 
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marigold extracts or oil. Special care must be taken 
by people who are allergic to species from the family 
Asteraceae [Corazza et al. 2014, Denisow-Pietrzyk and 
Pietrzyk 2019]. The most common reaction is skin al-
lergies (contact sensitization), as reported by the Amer-
ican Food and Drug Administration [FDA, Reider et 
al. 2001] and European Medicines Agency [EMA].
conclusions  
Marigold flower is currently a widely available raw 
material, valuable in terms of biological, medicinal, 
cosmetic and food properties. Research studies con-
firmed strong anti-inflammatory and antioxidant prop-
erties of this raw material; in addition, they demon-
strated other very important effects of its biological 
activity, such as hepatoregenerative, cardioprotective, 
neuroprotective and anticancer properties.
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